Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Upgrade
Needham upgrades Boston Scientific to Buy, sees stock as potential M&A target » 07:46
05/27/22
05/27
07:46
05/27/22
07:46
BSX

Boston Scientific

$40.15 /

+0.07 (+0.17%)

, JNJ

Johnson & Johnson

$179.50 /

+0.2 (+0.11%)

Needham analyst Mike…

Needham analyst Mike Matson upgraded Boston Scientific (BSX) to Buy from Hold with a $48 price target. The company could likely sustain high single digit growth even assuming a moderate WATCHMAN slowdown as it has numerous new products across most of its businesses that could serve as an offset, the analyst tells investors in a research note. With Johnson & Johnson's (JNJ) M&A plans coming into focus as it spins off its consumer business, Boston Scientific could be its target and a "good fit", Matson adds.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$179.50 /

+0.2 (+0.11%)

BSX Boston Scientific
$40.15 /

+0.07 (+0.17%)

BSX Boston Scientific
$40.15 /

+0.07 (+0.17%)

05/27/22 Needham
Boston Scientific upgraded to Buy from Hold at Needham
05/17/22 Citi
Boston Scientific price target lowered to $47 from $52 at Citi
05/16/22 Morgan Stanley
Boston Scientific named a 'Top Pick' at Morgan Stanley after meeting with CEO
05/03/22 Piper Sandler
Piper raises Zimmer Biomet target to $130, but sees 'better large caps to own'
JNJ Johnson & Johnson
$179.50 /

+0.2 (+0.11%)

05/23/22 SVB Leerink
Johnson & Johnson assumed with an Outperform at SVB Leerink
05/17/22 BofA
Teva upgraded to Neutral at BofA on potential opioid deal upside
05/17/22 Citi
Johnson & Johnson price target lowered to $205 from $210 at Citi
04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
JNJ Johnson & Johnson
$179.50 /

+0.2 (+0.11%)

BSX Boston Scientific
$40.15 /

+0.07 (+0.17%)

JNJ Johnson & Johnson
$179.50 /

+0.2 (+0.11%)

BSX Boston Scientific
$40.15 /

+0.07 (+0.17%)

JNJ Johnson & Johnson
$179.50 /

+0.2 (+0.11%)

BSX Boston Scientific
$40.15 /

+0.07 (+0.17%)

JNJ Johnson & Johnson
$179.50 /

+0.2 (+0.11%)

BSX Boston Scientific
$40.15 /

+0.07 (+0.17%)

Upgrade
Boston Scientific upgraded to Buy from Hold at Needham » 05:52
05/27/22
05/27
05:52
05/27/22
05:52
BSX

Boston Scientific

$40.15 /

+0.07 (+0.17%)

Needham analyst Mike…

Needham analyst Mike Matson upgraded Boston Scientific to Buy from Hold with a $48 price target.

ShowHide Related Items >><<
BSX Boston Scientific
$40.15 /

+0.07 (+0.17%)

BSX Boston Scientific
$40.15 /

+0.07 (+0.17%)

05/17/22 Citi
Boston Scientific price target lowered to $47 from $52 at Citi
05/16/22 Morgan Stanley
Boston Scientific named a 'Top Pick' at Morgan Stanley after meeting with CEO
05/03/22 Piper Sandler
Piper raises Zimmer Biomet target to $130, but sees 'better large caps to own'
04/27/22 Piper Sandler
Boston Scientific beat and modest raise 'a welcome sight,' says Piper Sandler
BSX Boston Scientific
$40.15 /

+0.07 (+0.17%)

BSX Boston Scientific
$40.15 /

+0.07 (+0.17%)

BSX Boston Scientific
$40.15 /

+0.07 (+0.17%)

BSX Boston Scientific
$40.15 /

+0.07 (+0.17%)

Hot Stocks
AbbVie announces results from three trials evaluating upadacitinib published » 05:05
05/27/22
05/27
05:05
05/27/22
05:05
ABBV

AbbVie

$150.66 /

-1.325 (-0.87%)

AbbVie announced The…

AbbVie announced The Lancet published results from three pivotal Phase 3 clinical trials - U-ACHIEVE induction, U-ACCOMPLISH and U-ACHIEVE maintenance - evaluating upadacitinib in patients with moderately to severely active ulcerative colitis who have had inadequate response, lost response or were intolerant to conventional or biologic therapy. Data from the three studies formed the basis of the company's application for approval by regulatory agencies. The publication reports the efficacy and safety results of the two induction studies and a maintenance study evaluating clinical remission and endoscopic improvement with oral upadacitinib versus placebo over 8 weeks and 52 weeks, respectively. The use of upadacitinib for ulcerative colitis is not approved in the European Union and its safety and efficacy remain under review by the global health authorities.

ShowHide Related Items >><<
ABBV AbbVie
$150.66 /

-1.325 (-0.87%)

ABBV AbbVie
$150.66 /

-1.325 (-0.87%)

05/23/22 SVB Leerink
AbbVie initiated with an Underperform at SVB Leerink
05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
ABBV AbbVie
$150.66 /

-1.325 (-0.87%)

ABBV AbbVie
$150.66 /

-1.325 (-0.87%)

ABBV AbbVie
$150.66 /

-1.325 (-0.87%)

ABBV AbbVie
$150.66 /

-1.325 (-0.87%)

Wednesday
Hot Stocks
West Virginia reaches $161M opioid settlement with Teva, AbbVie » 11:26
05/25/22
05/25
11:26
05/25/22
11:26
ABBV

AbbVie

$152.29 /

+3.18 (+2.13%)

, TEVA

Teva

$8.75 /

+0.29 (+3.43%)

West Virginia Attorney…

West Virginia Attorney General Patrick Morrisey announced a $161.53M settlement with drug manufacturers Teva Pharmaceutical Industries (TEVA) and AbbVie's (ABBV) Allergan. Throughout the trial, which began on April 4, the Attorney General "alleged the manufacturers helped fuel the opioid epidemic in West Virginia by engaging in strategic campaigns to deceive prescribers and misrepresent the risks and benefits of opioid painkillers." According to the settlement, West Virginia will receive payments totaling more than $134.53M in cash over the length of the agreement provided that the state has received sign-ons from its political subdivisions. Teva, as part of the settlement, will also supply West Virginia with $27M worth of Narcan. Reference Link

ShowHide Related Items >><<
TEVA Teva
$8.75 /

+0.29 (+3.43%)

ABBV AbbVie
$152.29 /

+3.18 (+2.13%)

ABBV AbbVie
$152.29 /

+3.18 (+2.13%)

05/23/22 SVB Leerink
AbbVie initiated with an Underperform at SVB Leerink
05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
TEVA Teva
$8.75 /

+0.29 (+3.43%)

05/17/22 BofA
Teva upgraded to Neutral at BofA on potential opioid deal upside
05/17/22 BofA
Teva upgraded to Neutral from Underperform at BofA
05/04/22 Piper Sandler
Teva downgraded to Underweight from Neutral at Piper Sandler
04/05/22 Barclays
Teva upgraded to Overweight from Equal Weight at Barclays
TEVA Teva
$8.75 /

+0.29 (+3.43%)

ABBV AbbVie
$152.29 /

+3.18 (+2.13%)

TEVA Teva
$8.75 /

+0.29 (+3.43%)

ABBV AbbVie
$152.29 /

+3.18 (+2.13%)

TEVA Teva
$8.75 /

+0.29 (+3.43%)

ABBV AbbVie
$152.29 /

+3.18 (+2.13%)

TEVA Teva
$8.75 /

+0.29 (+3.43%)

ABBV AbbVie
$152.29 /

+3.18 (+2.13%)

Monday
On The Fly
What You Missed On Wall Street On Monday » 16:24
05/23/22
05/23
16:24
05/23/22
16:24
VMW

VMware

$119.43 /

+23.72 (+24.78%)

, AVGO

Broadcom

$526.26 /

-17.93 (-3.29%)

, EA

Electronic Arts

$133.78 /

+3.09 (+2.36%)

, SBUX

Starbucks

$73.38 /

-0.02 (-0.03%)

, JPM

JPMorgan

$124.55 /

+7.17 (+6.11%)

, ETTX

Entasis Therapeutics

$2.18 /

+0.36 (+19.83%)

, INVA

Innoviva

$16.35 /

+0.055 (+0.34%)

, AXL

American Axle

$7.22 /

+0.47 (+6.96%)

, NTNX

Nutanix

$21.73 /

+1.07 (+5.18%)

, GPS

Gap

$10.33 /

-0.6 (-5.49%)

, XPEV

XPeng

$21.91 /

-1.375 (-5.91%)

, HPQ

HP Inc.

$35.08 /

+0.42 (+1.21%)

, NVDA

Nvidia

$168.96 /

+1.775 (+1.06%)

, ADSK

Autodesk

$183.69 /

-7.81 (-4.08%)

, ABBV

AbbVie

$148.01 /

-3.03 (-2.01%)

, ANF

Abercrombie & Fitch

$26.74 /

-1.25 (-4.47%)

, AEO

American Eagle

$12.93 /

-0.39 (-2.93%)

, CRI

Carter's

$75.40 /

-0.09 (-0.12%)

, PLCE

Children's Place

$43.96 /

-1.66 (-3.64%)

, KSS

Kohl's

$38.39 /

-0.79 (-2.02%)

, RL

Ralph Lauren

$90.90 /

-2.34 (-2.51%)

, UA

Under Armour

$8.68 /

+0.21 (+2.48%)

, UAA

Under Armour

$9.69 /

+0.06 (+0.62%)

, TSLA

Tesla

$674.82 /

+10.72 (+1.61%)

, TWTR

Twitter

$37.86 /

-0.42 (-1.10%)

, AAPL

Apple

$143.06 /

+5.48 (+3.98%)

, AMZN

Amazon.com

$2,150.14 /

-2.97 (-0.14%)

, GILT

Gilat Satellite

$6.82 /

+0.08 (+1.19%)

, RSLS

ReShape Lifesciences

/

+

, TBLT

ToughBuilt

$6.04 /

-0.755 (-11.12%)

, TFX

Teleflex

$289.46 /

+2.37 (+0.83%)

, UTHR

United Therapeutics

$210.20 /

+21.735 (+11.53%)

, ENV

Envestnet

$64.09 /

-5.91 (-8.44%)

Get caught up quickly on…

ShowHide Related Items >><<
XPEV XPeng
$21.91 /

-1.375 (-5.91%)

VMW VMware
$119.43 /

+23.72 (+24.78%)

UTHR United Therapeutics
$210.20 /

+21.735 (+11.53%)

UAA Under Armour
$9.69 /

+0.06 (+0.62%)

UA Under Armour
$8.68 /

+0.21 (+2.48%)

TWTR Twitter
$37.86 /

-0.42 (-1.10%)

TSLA Tesla
$674.82 /

+10.72 (+1.61%)

TFX Teleflex
$289.46 /

+2.37 (+0.83%)

TBLT ToughBuilt
$6.04 /

-0.755 (-11.12%)

SBUX Starbucks
$73.38 /

-0.02 (-0.03%)

RSLS ReShape Lifesciences
/

+

RL Ralph Lauren
$90.90 /

-2.34 (-2.51%)

PLCE Children's Place
$43.96 /

-1.66 (-3.64%)

NVDA Nvidia
$168.96 /

+1.775 (+1.06%)

NTNX Nutanix
$21.73 /

+1.07 (+5.18%)

KSS Kohl's
$38.39 /

-0.79 (-2.02%)

JPM JPMorgan
$124.55 /

+7.17 (+6.11%)

INVA Innoviva
$16.35 /

+0.055 (+0.34%)

HPQ HP Inc.
$35.08 /

+0.42 (+1.21%)

GPS Gap
$10.33 /

-0.6 (-5.49%)

GILT Gilat Satellite
$6.82 /

+0.08 (+1.19%)

ETTX Entasis Therapeutics
$2.18 /

+0.36 (+19.83%)

ENV Envestnet
$64.09 /

-5.91 (-8.44%)

EA Electronic Arts
$133.78 /

+3.09 (+2.36%)

CRI Carter's
$75.40 /

-0.09 (-0.12%)

AXL American Axle
$7.22 /

+0.47 (+6.96%)

AVGO Broadcom
$526.26 /

-17.93 (-3.29%)

ANF Abercrombie & Fitch
$26.74 /

-1.25 (-4.47%)

AMZN Amazon.com
$2,150.14 /

-2.97 (-0.14%)

AEO American Eagle
$12.93 /

-0.39 (-2.93%)

ADSK Autodesk
$183.69 /

-7.81 (-4.08%)

ABBV AbbVie
$148.01 /

-3.03 (-2.01%)

AAPL Apple
$143.06 /

+5.48 (+3.98%)

VMW VMware
$119.43 /

+23.72 (+24.78%)

05/24/22 Mizuho
Broadcom could triple software revenue with VMware, says Mizuho
05/24/22 Piper Sandler
Broadcom deal for VMware 'makes perfect sense,' says Piper Sandler
05/23/22 Jefferies
VMware price target lowered to $105 from $125 at Jefferies
05/23/22 RBC Capital
VMware price target lowered to $140 from $153 at RBC Capital
AVGO Broadcom
$526.26 /

-17.93 (-3.29%)

05/23/22 BofA
Deal for VMware would be synergistic with Broadcom strategy, says BofA
05/23/22 Piper Sandler
VMware passes Broadcom deal 'smell-test,' says Piper Sandler
EA Electronic Arts
$133.78 /

+3.09 (+2.36%)

05/23/22 Jefferies
Odds favor no EA deal over a deal for next several quarters, says Jefferies
05/23/22 Raymond James
Electronic Arts moves 'somewhat unexpected,' says Raymond James
05/17/22 Morgan Stanley
Take-Two price target lowered to $195 from $215 at Morgan Stanley
05/11/22 Wells Fargo
Electronic Arts price target lowered to $145 from $155 at Wells Fargo
SBUX Starbucks
$73.38 /

-0.02 (-0.03%)

05/09/22 Deutsche Bank
Starbucks price target lowered to $103 from $116 at Deutsche Bank
05/04/22 MKM Partners
Starbucks price target lowered to $98 from $105 at MKM Partners
05/04/22 Morgan Stanley
Starbucks price target lowered to $87 from $94 at Morgan Stanley
05/04/22 Cowen
Starbucks price target lowered to $94 from $115 at Cowen
JPM JPMorgan
$124.55 /

+7.17 (+6.11%)

05/24/22 BofA
JPMorgan event highlighted 'scale and top notch execution,' says BofA
05/24/22 Wells Fargo
JPMorgan price target raised to $150 from $145 at Wells Fargo
05/24/22 Keefe Bruyette
JPMorgan price target raised to $148 from $142 at Keefe Bruyette
05/24/22 Baird
JPMorgan valuation suggests balanced risk/reward, says Baird
ETTX Entasis Therapeutics
$2.18 /

+0.36 (+19.83%)

05/06/22 Cantor Fitzgerald
Entasis Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
05/06/22 Cantor Fitzgerald
Entasis downgraded to Neutral from Overweight at Cantor Fitzgerald
03/16/22 Alliance Global Partners
Entasis Therapeutics downgraded to Neutral from Buy at Alliance Global Partners
03/08/22 Wedbush
Entasis Therapeutics downgraded to Neutral from Outperform at Wedbush
INVA Innoviva
$16.35 /

+0.055 (+0.34%)

03/04/22 H.C. Wainwright
Entasis Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
02/11/22 EF Hutton
Innoviva initiated with a Buy at EF Hutton
AXL American Axle
$7.22 /

+0.47 (+6.96%)

05/10/22 Barclays
American Axle price target lowered to $5 from $6 at Barclays
04/21/22 Deutsche Bank
American Axle price target lowered to $8 from $10 at Deutsche Bank
04/11/22 Exane BNP Paribas
American Axle initiated with a Neutral at Exane BNP Paribas
04/07/22 Barclays
American Axle price target lowered to $6 from $7 at Barclays
NTNX Nutanix
$21.73 /

+1.07 (+5.18%)

04/12/22 Morgan Stanley
Nutanix price target lowered to $31 from $32 at Morgan Stanley
04/12/22 Morgan Stanley
Morgan Stanley cuts Telecom & Networking Equipment industry view to Cautious
03/03/22 Needham
Nutanix price target lowered to $34 from $71 at Needham
03/03/22 Wells Fargo
Nutanix price target lowered to $35 from $40 at Wells Fargo
GPS Gap
$10.33 /

-0.6 (-5.49%)

05/23/22 Citi
Gap downgraded to Sell from Neutral at Citi
05/17/22 UBS
Gap price target lowered to $14 from $18 at UBS
05/16/22 JPMorgan
Gap price target lowered to $11 from $14 at JPMorgan
04/25/22 Guggenheim
Guggenheim upgrades Gap to Buy with shares 70% off highs
XPEV XPeng
$21.91 /

-1.375 (-5.91%)

05/24/22 Barclays
XPeng price target lowered to $30 from $39 at Barclays
05/24/22 BofA
XPeng price target lowered to $40 from $46 at BofA
04/01/22 HSBC
XPeng initiated with a Buy at HSBC
03/29/22 Citi
Citi reiterates XPeng as top sector pick on 'very strong' backlog
HPQ HP Inc.
$35.08 /

+0.42 (+1.21%)

05/23/22 Citi
HP Inc. downgraded to Neutral from Buy at Citi
05/18/22 Jefferies
Information Technology sector upgraded to Bullish at Jefferies
05/16/22 Evercore ISI
HP Inc. added to 'Tactical Outperform' list at Evercore ISI
04/08/22 UBS
HP Inc. downgraded to Neutral from Buy at UBS
NVDA Nvidia
$168.96 /

+1.775 (+1.06%)

05/23/22 Bernstein
Nvidia price target lowered to $225 from $325 at Bernstein
05/23/22 UBS
Nvidia price target lowered to $280 from $350 at UBS
05/20/22 Wells Fargo
Nvidia price target lowered to $250 from $370 at Wells Fargo
05/20/22 Daiwa
Daiwa sees six month 'danger zone' for semiconductor stocks
ADSK Autodesk
$183.69 /

-7.81 (-4.08%)

05/23/22 Stifel
Autodesk price target lowered to $230 from $285 at Stifel
05/23/22 RBC Capital
Autodesk price target lowered to $255 from $295 at RBC Capital
05/23/22 Deutsche Bank
Deutsche Bank downgrades Autodesk on risk to consensus estimates
05/23/22 Deutsche Bank
Autodesk downgraded to Hold from Buy at Deutsche Bank
ABBV AbbVie
$148.01 /

-3.03 (-2.01%)

05/23/22 SVB Leerink
AbbVie initiated with an Underperform at SVB Leerink
05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
ANF Abercrombie & Fitch
$26.74 /

-1.25 (-4.47%)

05/23/22 Citi
Abercrombie & Fitch downgraded to Neutral from Buy at Citi
05/16/22 JPMorgan
Abercrombie & Fitch price target raised to $39 from $35 at JPMorgan
04/11/22 JPMorgan
Abercrombie & Fitch price target lowered to $35 from $41 at JPMorgan
03/16/22 B. Riley
B. Riley says teen/young adult apparel 'poised for a breakout'
AEO American Eagle
$12.93 /

-0.39 (-2.93%)

05/23/22 Citi
American Eagle downgraded to Neutral from Buy at Citi
05/17/22 B. Riley
American Eagle price target lowered to $32 from $41 at B. Riley
05/16/22 JPMorgan
American Eagle price target lowered to $20 from $29 at JPMorgan
04/11/22 JPMorgan
American Eagle price target lowered to $29 from $32 at JPMorgan
CRI Carter's
$75.40 /

-0.09 (-0.12%)

05/23/22 Citi
Carter's downgraded to Sell from Buy at Citi
04/27/22 BofA
Carter's downgraded to Underperform from Buy at BofA
04/05/22 Wells Fargo
Carter's price target lowered to $95 from $105 at Wells Fargo
03/07/22 Wedbush
Carter's upgraded to Outperform from Neutral at Wedbush
PLCE Children's Place
$43.96 /

-1.66 (-3.64%)

05/23/22 Citi
Children's Place downgraded to Sell from Neutral at Citi
05/20/22 Citi
Children's Place price target lowered to $48 from $60 at Citi
05/17/22 B. Riley
Children's Place price target lowered to $84 from $105 at B. Riley
03/23/22 UBS
Children's Place price target lowered to $60 from $85 at UBS
KSS Kohl's
$38.39 /

-0.79 (-2.02%)

05/23/22 Citi
Kohl's downgraded to Neutral from Buy at Citi
05/20/22 Morgan Stanley
Kohl's price target lowered to $38 from $42 at Morgan Stanley
05/20/22 Cowen
Kohl's price target lowered to $60 from $75 at Cowen
05/20/22 Deutsche Bank
Kohl's price target lowered to $68 from $85 at Deutsche Bank
RL Ralph Lauren
$90.90 /

-2.34 (-2.51%)

05/23/22 Citi
Ralph Lauren downgraded to Neutral from Buy at Citi
05/18/22 Credit Suisse
Ralph Lauren price target lowered to $130 from $165 at Credit Suisse
05/16/22 Deutsche Bank
Ralph Lauren price target lowered to $116 from $136 at Deutsche Bank
04/05/22 Wells Fargo
Ralph Lauren downgraded to Equal Weight from Overweight at Wells Fargo
UA Under Armour
$8.68 /

+0.21 (+2.48%)

05/23/22 Citi
Under Armour downgraded to Neutral from Buy at Citi
05/19/22 Morgan Stanley
Under Armour downgraded to Equal Weight from Overweight at Morgan Stanley
05/10/22 Barclays
Under Armour price target lowered to $14 from $22 at Barclays
05/09/22 B. Riley
Under Armour price target lowered to $11 from $18 at B. Riley
UAA Under Armour
$9.69 /

+0.06 (+0.62%)

05/19/22 Williams Trading
Under Armour downgraded to Hold from Buy at Williams Trading
05/11/22 Argus
Under Armour price target lowered to $15 from $19 at Argus
TSLA Tesla
$674.82 /

+10.72 (+1.61%)

05/24/22 Wedbush
More fireworks expected heading into Twitter shareholder meeting, says Wedbush
05/24/22 Bernstein
Bernstein says Tesla-Twitter saga far from over, discusses funding requirements
05/24/22 Daiwa
Tesla price target lowered to $800 from $1,150 at Daiwa
05/23/22 Mizuho
Nio could be back to pre-shutdown levels by June, says Mizuho
TWTR Twitter
$37.86 /

-0.42 (-1.10%)

05/24/22 KeyBanc
Snap price target lowered to $27 from $45 at KeyBanc
05/17/22 Wedbush
Tesla shares likely to be under pressure again Tuesday, says Wedbush
AAPL Apple
$143.06 /

+5.48 (+3.98%)

05/24/22 BofA
Apple App Store growth has re-accelerated modestly, says BofA
05/24/22 Benchmark
Snap price target lowered to $20 from $40 at Benchmark
05/23/22 UBS
UBS finds solid iPhone purchase demand in China, modest U.S. downtick for Apple
AMZN Amazon.com
$2,150.14 /

-2.97 (-0.14%)

05/20/22 Citi
Amazon.com removed from Focus List at Citi
05/10/22 Morgan Stanley
Expectations for Affirm outlook 'meaningfully' lower, says Morgan Stanley
05/10/22 Morgan Stanley
Morgan Stanley sees 300% upside potential for Rivian in base case
GILT Gilat Satellite
$6.82 /

+0.08 (+1.19%)

RSLS ReShape Lifesciences
/

+

03/29/22 Alliance Global Partners
ReShape Lifesciences target cut to $5.50 from $10.25 at Alliance Global Partners
03/29/22 Maxim
ReShape Lifesciences price target lowered to $4 from $8 at Maxim
10/08/21 Maxim
ReShape Lifesciences initiated with a Buy at Maxim
10/08/21 Maxim
ReShape Lifesciences initiated with a Buy at Maxim
TBLT ToughBuilt
$6.04 /

-0.755 (-11.12%)

10/19/21 H.C. Wainwright
ToughBuilt initiated with a Buy at H.C. Wainwright
TFX Teleflex
$289.46 /

+2.37 (+0.83%)

05/23/22 Truist
Teleflex price target lowered to $317 from $340 at Truist
05/23/22 RBC Capital
Teleflex price target lowered to $380 from $390 at RBC Capital
05/09/22 BofA
Teleflex initiated with a Neutral at BofA
04/29/22 Truist
Teleflex price target lowered to $340 from $370 at Truist
UTHR United Therapeutics
$210.20 /

+21.735 (+11.53%)

05/24/22 Wedbush
United Therapeutics price target raised to $263 from $236 at Wedbush
05/24/22 Credit Suisse
United Therapeutics price target raised to $247 from $219 at Credit Suisse
05/24/22 H.C. Wainwright
United Therapeutics price target raised to $255 from $248 at H.C. Wainwright
05/05/22 Oppenheimer
United Therapeutics price target raised to $300 from $275 at Oppenheimer
ENV Envestnet
$64.09 /

-5.91 (-8.44%)

04/12/22 Jefferies
Envestnet PE deal could be done in '$90-$95 range,' says Jefferies
03/07/22 Truist
Envestnet price target lowered to $90 from $95 at Truist
02/28/22 DA Davidson
Envestnet upgraded to Buy at DA Davidson on Friday on valuation, solid Q4
02/25/22 DA Davidson
Envestnet upgraded to Buy from Neutral at DA Davidson
XPEV XPeng
$21.91 /

-1.375 (-5.91%)

VMW VMware
$119.43 /

+23.72 (+24.78%)

UTHR United Therapeutics
$210.20 /

+21.735 (+11.53%)

UA Under Armour
$8.68 /

+0.21 (+2.48%)

TWTR Twitter
$37.86 /

-0.42 (-1.10%)

TSLA Tesla
$674.82 /

+10.72 (+1.61%)

TFX Teleflex
$289.46 /

+2.37 (+0.83%)

TBLT ToughBuilt
$6.04 /

-0.755 (-11.12%)

SBUX Starbucks
$73.38 /

-0.02 (-0.03%)

RSLS ReShape Lifesciences
/

+

RL Ralph Lauren
$90.90 /

-2.34 (-2.51%)

PLCE Children's Place
$43.96 /

-1.66 (-3.64%)

NVDA Nvidia
$168.96 /

+1.775 (+1.06%)

NTNX Nutanix
$21.73 /

+1.07 (+5.18%)

KSS Kohl's
$38.39 /

-0.79 (-2.02%)

JPM JPMorgan
$124.55 /

+7.17 (+6.11%)

HPQ HP Inc.
$35.08 /

+0.42 (+1.21%)

GPS Gap
$10.33 /

-0.6 (-5.49%)

GILT Gilat Satellite
$6.82 /

+0.08 (+1.19%)

ETTX Entasis Therapeutics
$2.18 /

+0.36 (+19.83%)

ENV Envestnet
$64.09 /

-5.91 (-8.44%)

EA Electronic Arts
$133.78 /

+3.09 (+2.36%)

CRI Carter's
$75.40 /

-0.09 (-0.12%)

AXL American Axle
$7.22 /

+0.47 (+6.96%)

AVGO Broadcom
$526.26 /

-17.93 (-3.29%)

ANF Abercrombie & Fitch
$26.74 /

-1.25 (-4.47%)

AMZN Amazon.com
$2,150.14 /

-2.97 (-0.14%)

AEO American Eagle
$12.93 /

-0.39 (-2.93%)

ADSK Autodesk
$183.69 /

-7.81 (-4.08%)

ABBV AbbVie
$148.01 /

-3.03 (-2.01%)

AAPL Apple
$143.06 /

+5.48 (+3.98%)

XPEV XPeng
$21.91 /

-1.375 (-5.91%)

VMW VMware
$119.43 /

+23.72 (+24.78%)

UA Under Armour
$8.68 /

+0.21 (+2.48%)

TWTR Twitter
$37.86 /

-0.42 (-1.10%)

TSLA Tesla
$674.82 /

+10.72 (+1.61%)

SBUX Starbucks
$73.38 /

-0.02 (-0.03%)

RL Ralph Lauren
$90.90 /

-2.34 (-2.51%)

NVDA Nvidia
$168.96 /

+1.775 (+1.06%)

NTNX Nutanix
$21.73 /

+1.07 (+5.18%)

KSS Kohl's
$38.39 /

-0.79 (-2.02%)

JPM JPMorgan
$124.55 /

+7.17 (+6.11%)

HPQ HP Inc.
$35.08 /

+0.42 (+1.21%)

GPS Gap
$10.33 /

-0.6 (-5.49%)

ENV Envestnet
$64.09 /

-5.91 (-8.44%)

EA Electronic Arts
$133.78 /

+3.09 (+2.36%)

AXL American Axle
$7.22 /

+0.47 (+6.96%)

AVGO Broadcom
$526.26 /

-17.93 (-3.29%)

AMZN Amazon.com
$2,150.14 /

-2.97 (-0.14%)

ABBV AbbVie
$148.01 /

-3.03 (-2.01%)

AAPL Apple
$143.06 /

+5.48 (+3.98%)

XPEV XPeng
$21.91 /

-1.375 (-5.91%)

VMW VMware
$119.43 /

+23.72 (+24.78%)

UTHR United Therapeutics
$210.20 /

+21.735 (+11.53%)

TWTR Twitter
$37.86 /

-0.42 (-1.10%)

TSLA Tesla
$674.82 /

+10.72 (+1.61%)

TFX Teleflex
$289.46 /

+2.37 (+0.83%)

SBUX Starbucks
$73.38 /

-0.02 (-0.03%)

RL Ralph Lauren
$90.90 /

-2.34 (-2.51%)

PLCE Children's Place
$43.96 /

-1.66 (-3.64%)

NVDA Nvidia
$168.96 /

+1.775 (+1.06%)

NTNX Nutanix
$21.73 /

+1.07 (+5.18%)

KSS Kohl's
$38.39 /

-0.79 (-2.02%)

JPM JPMorgan
$124.55 /

+7.17 (+6.11%)

GPS Gap
$10.33 /

-0.6 (-5.49%)

GILT Gilat Satellite
$6.82 /

+0.08 (+1.19%)

ETTX Entasis Therapeutics
$2.18 /

+0.36 (+19.83%)

ENV Envestnet
$64.09 /

-5.91 (-8.44%)

EA Electronic Arts
$133.78 /

+3.09 (+2.36%)

CRI Carter's
$75.40 /

-0.09 (-0.12%)

AXL American Axle
$7.22 /

+0.47 (+6.96%)

AVGO Broadcom
$526.26 /

-17.93 (-3.29%)

ANF Abercrombie & Fitch
$26.74 /

-1.25 (-4.47%)

AMZN Amazon.com
$2,150.14 /

-2.97 (-0.14%)

AEO American Eagle
$12.93 /

-0.39 (-2.93%)

ADSK Autodesk
$183.69 /

-7.81 (-4.08%)

ABBV AbbVie
$148.01 /

-3.03 (-2.01%)

XPEV XPeng
$21.91 /

-1.375 (-5.91%)

VMW VMware
$119.43 /

+23.72 (+24.78%)

UAA Under Armour
$9.69 /

+0.06 (+0.62%)

UA Under Armour
$8.68 /

+0.21 (+2.48%)

TWTR Twitter
$37.86 /

-0.42 (-1.10%)

TSLA Tesla
$674.82 /

+10.72 (+1.61%)

SBUX Starbucks
$73.38 /

-0.02 (-0.03%)

RL Ralph Lauren
$90.90 /

-2.34 (-2.51%)

NVDA Nvidia
$168.96 /

+1.775 (+1.06%)

NTNX Nutanix
$21.73 /

+1.07 (+5.18%)

KSS Kohl's
$38.39 /

-0.79 (-2.02%)

JPM JPMorgan
$124.55 /

+7.17 (+6.11%)

HPQ HP Inc.
$35.08 /

+0.42 (+1.21%)

GPS Gap
$10.33 /

-0.6 (-5.49%)

EA Electronic Arts
$133.78 /

+3.09 (+2.36%)

AVGO Broadcom
$526.26 /

-17.93 (-3.29%)

AMZN Amazon.com
$2,150.14 /

-2.97 (-0.14%)

AEO American Eagle
$12.93 /

-0.39 (-2.93%)

ADSK Autodesk
$183.69 /

-7.81 (-4.08%)

ABBV AbbVie
$148.01 /

-3.03 (-2.01%)

AAPL Apple
$143.06 /

+5.48 (+3.98%)

On The Fly
What You Missed On Wall Street This Morning » 12:03
05/23/22
05/23
12:03
05/23/22
12:03
VMW

VMware

$115.50 /

+19.79 (+20.68%)

, AVGO

Broadcom

$530.00 /

-14.19 (-2.61%)

, EA

Electronic Arts

$133.71 /

+3.02 (+2.31%)

, SBUX

Starbucks

$73.88 /

+0.48 (+0.65%)

, JPM

JPMorgan

$126.15 /

+8.77 (+7.47%)

, ETTX

Entasis Therapeutics

$2.18 /

+0.365 (+20.11%)

, INVA

Innoviva

$16.43 /

+0.14 (+0.86%)

, AXL

American Axle

$7.55 /

+0.8 (+11.85%)

, NTNX

Nutanix

$21.91 /

+1.25 (+6.05%)

, DIDI

Didi

$1.53 /

+0.025 (+1.66%)

, GPS

Gap

$10.61 /

-0.32 (-2.93%)

, XPEV

XPeng

$21.58 /

-1.705 (-7.32%)

, HPQ

HP Inc.

$34.73 /

+0.07 (+0.20%)

, NVDA

Nvidia

$166.37 /

-0.81 (-0.48%)

, ADSK

Autodesk

$181.21 /

-10.295 (-5.38%)

, ABBV

AbbVie

$150.38 /

-0.66 (-0.44%)

, ANF

Abercrombie & Fitch

$27.32 /

-0.67 (-2.39%)

, AEO

American Eagle

$13.23 /

-0.09 (-0.68%)

, CRI

Carter's

$76.62 /

+1.13 (+1.50%)

, PLCE

Children's Place

$43.55 /

-2.07 (-4.54%)

, KSS

Kohl's

$39.31 /

+0.13 (+0.33%)

, RL

Ralph Lauren

$91.91 /

-1.33 (-1.43%)

, UA

Under Armour

$8.51 /

+0.04 (+0.47%)

, UAA

Under Armour

$9.61 /

-0.02 (-0.21%)

, TSLA

Tesla

$665.05 /

+0.95 (+0.14%)

, TWTR

Twitter

$37.73 /

-0.55 (-1.44%)

, AAPL

Apple

$141.26 /

+3.68 (+2.67%)

, AMZN

Amazon.com

$2,108.51 /

-44.6 (-2.07%)

, GILT

Gilat Satellite

$6.86 /

+0.125 (+1.86%)

, RSLS

ReShape Lifesciences

/

+

, TBLT

ToughBuilt

$6.36 /

-0.43 (-6.33%)

, TFX

Teleflex

$288.18 /

+1.09 (+0.38%)

, STRR

Star Equity

/

+

Get caught up quickly on…

ShowHide Related Items >><<
XPEV XPeng
$21.58 /

-1.705 (-7.32%)

VMW VMware
$115.50 /

+19.79 (+20.68%)

UAA Under Armour
$9.61 /

-0.02 (-0.21%)

UA Under Armour
$8.51 /

+0.04 (+0.47%)

TWTR Twitter
$37.73 /

-0.55 (-1.44%)

TSLA Tesla
$665.05 /

+0.95 (+0.14%)

TFX Teleflex
$288.18 /

+1.09 (+0.38%)

TBLT ToughBuilt
$6.36 /

-0.43 (-6.33%)

STRR Star Equity
/

+

SBUX Starbucks
$73.88 /

+0.48 (+0.65%)

RSLS ReShape Lifesciences
/

+

RL Ralph Lauren
$91.91 /

-1.33 (-1.43%)

PLCE Children's Place
$43.55 /

-2.07 (-4.54%)

NVDA Nvidia
$166.37 /

-0.81 (-0.48%)

NTNX Nutanix
$21.91 /

+1.25 (+6.05%)

KSS Kohl's
$39.31 /

+0.13 (+0.33%)

JPM JPMorgan
$126.15 /

+8.77 (+7.47%)

INVA Innoviva
$16.43 /

+0.14 (+0.86%)

HPQ HP Inc.
$34.73 /

+0.07 (+0.20%)

GPS Gap
$10.61 /

-0.32 (-2.93%)

GILT Gilat Satellite
$6.86 /

+0.125 (+1.86%)

ETTX Entasis Therapeutics
$2.18 /

+0.365 (+20.11%)

EA Electronic Arts
$133.71 /

+3.02 (+2.31%)

DIDI Didi
$1.53 /

+0.025 (+1.66%)

CRI Carter's
$76.62 /

+1.13 (+1.50%)

AXL American Axle
$7.55 /

+0.8 (+11.85%)

AVGO Broadcom
$530.00 /

-14.19 (-2.61%)

ANF Abercrombie & Fitch
$27.32 /

-0.67 (-2.39%)

AMZN Amazon.com
$2,108.51 /

-44.6 (-2.07%)

AEO American Eagle
$13.23 /

-0.09 (-0.68%)

ADSK Autodesk
$181.21 /

-10.295 (-5.38%)

ABBV AbbVie
$150.38 /

-0.66 (-0.44%)

AAPL Apple
$141.26 /

+3.68 (+2.67%)

VMW VMware
$115.50 /

+19.79 (+20.68%)

05/23/22 Jefferies
VMware price target lowered to $105 from $125 at Jefferies
05/23/22 RBC Capital
VMware price target lowered to $140 from $153 at RBC Capital
05/23/22 BofA
Deal for VMware would be synergistic with Broadcom strategy, says BofA
05/23/22 Piper Sandler
VMware passes Broadcom deal 'smell-test,' says Piper Sandler
AVGO Broadcom
$530.00 /

-14.19 (-2.61%)

05/20/22 Daiwa
Daiwa sees six month 'danger zone' for semiconductor stocks
05/17/22 Piper Sandler
Piper moves to 'more positive stance' on semiconductor stocks
EA Electronic Arts
$133.71 /

+3.02 (+2.31%)

05/23/22 Jefferies
Odds favor no EA deal over a deal for next several quarters, says Jefferies
05/23/22 Raymond James
Electronic Arts moves 'somewhat unexpected,' says Raymond James
05/17/22 Morgan Stanley
Take-Two price target lowered to $195 from $215 at Morgan Stanley
05/11/22 Wells Fargo
Electronic Arts price target lowered to $145 from $155 at Wells Fargo
SBUX Starbucks
$73.88 /

+0.48 (+0.65%)

05/09/22 Deutsche Bank
Starbucks price target lowered to $103 from $116 at Deutsche Bank
05/04/22 MKM Partners
Starbucks price target lowered to $98 from $105 at MKM Partners
05/04/22 Morgan Stanley
Starbucks price target lowered to $87 from $94 at Morgan Stanley
05/04/22 Cowen
Starbucks price target lowered to $94 from $115 at Cowen
JPM JPMorgan
$126.15 /

+8.77 (+7.47%)

05/13/22 Jefferies
JPMorgan price target lowered to $125 from $141 at Jefferies
05/03/22 Oppenheimer
Oppenheimer upgrades JPMorgan to Outperform on recent share weakness
05/03/22 Oppenheimer
JPMorgan upgraded to Outperform from Perform at Oppenheimer
04/14/22 Argus
JPMorgan price target lowered to $155 from $177 at Argus
ETTX Entasis Therapeutics
$2.18 /

+0.365 (+20.11%)

05/06/22 Cantor Fitzgerald
Entasis Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
05/06/22 Cantor Fitzgerald
Entasis downgraded to Neutral from Overweight at Cantor Fitzgerald
03/16/22 Alliance Global Partners
Entasis Therapeutics downgraded to Neutral from Buy at Alliance Global Partners
03/08/22 Wedbush
Entasis Therapeutics downgraded to Neutral from Outperform at Wedbush
INVA Innoviva
$16.43 /

+0.14 (+0.86%)

03/04/22 H.C. Wainwright
Entasis Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
02/11/22 EF Hutton
Innoviva initiated with a Buy at EF Hutton
AXL American Axle
$7.55 /

+0.8 (+11.85%)

05/10/22 Barclays
American Axle price target lowered to $5 from $6 at Barclays
04/21/22 Deutsche Bank
American Axle price target lowered to $8 from $10 at Deutsche Bank
04/11/22 Exane BNP Paribas
American Axle initiated with a Neutral at Exane BNP Paribas
04/07/22 Barclays
American Axle price target lowered to $6 from $7 at Barclays
NTNX Nutanix
$21.91 /

+1.25 (+6.05%)

04/12/22 Morgan Stanley
Nutanix price target lowered to $31 from $32 at Morgan Stanley
04/12/22 Morgan Stanley
Morgan Stanley cuts Telecom & Networking Equipment industry view to Cautious
03/03/22 Needham
Nutanix price target lowered to $34 from $71 at Needham
03/03/22 Wells Fargo
Nutanix price target lowered to $35 from $40 at Wells Fargo
DIDI Didi
$1.53 /

+0.025 (+1.66%)

03/16/22 US Tiger
China Internet sector upgraded to Outperform from Neutral at US Tiger
02/14/22 Bernstein
Didi initiated with an Outperform at Bernstein
07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
GPS Gap
$10.61 /

-0.32 (-2.93%)

05/23/22 Citi
Gap downgraded to Sell from Neutral at Citi
05/17/22 UBS
Gap price target lowered to $14 from $18 at UBS
05/16/22 JPMorgan
Gap price target lowered to $11 from $14 at JPMorgan
04/25/22 Guggenheim
Guggenheim upgrades Gap to Buy with shares 70% off highs
XPEV XPeng
$21.58 /

-1.705 (-7.32%)

04/01/22 HSBC
XPeng initiated with a Buy at HSBC
03/29/22 Citi
Citi reiterates XPeng as top sector pick on 'very strong' backlog
03/29/22 Barclays
XPeng price target lowered to $39 from $45 at Barclays
03/28/22 US Tiger
XPeng upgraded to Buy from Hold at US Tiger
HPQ HP Inc.
$34.73 /

+0.07 (+0.20%)

05/23/22 Citi
HP Inc. downgraded to Neutral from Buy at Citi
05/18/22 Jefferies
Information Technology sector upgraded to Bullish at Jefferies
05/16/22 Evercore ISI
HP Inc. added to 'Tactical Outperform' list at Evercore ISI
04/08/22 UBS
HP Inc. downgraded to Neutral from Buy at UBS
NVDA Nvidia
$166.37 /

-0.81 (-0.48%)

05/23/22 Bernstein
Nvidia price target lowered to $225 from $325 at Bernstein
05/23/22 UBS
Nvidia price target lowered to $280 from $350 at UBS
05/20/22 Wells Fargo
Nvidia price target lowered to $250 from $370 at Wells Fargo
ADSK Autodesk
$181.21 /

-10.295 (-5.38%)

05/23/22 Stifel
Autodesk price target lowered to $230 from $285 at Stifel
05/23/22 RBC Capital
Autodesk price target lowered to $255 from $295 at RBC Capital
05/23/22 Deutsche Bank
Deutsche Bank downgrades Autodesk on risk to consensus estimates
05/23/22 Deutsche Bank
Autodesk downgraded to Hold from Buy at Deutsche Bank
ABBV AbbVie
$150.38 /

-0.66 (-0.44%)

05/23/22 SVB Leerink
AbbVie initiated with an Underperform at SVB Leerink
05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
ANF Abercrombie & Fitch
$27.32 /

-0.67 (-2.39%)

05/23/22 Citi
Abercrombie & Fitch downgraded to Neutral from Buy at Citi
05/16/22 JPMorgan
Abercrombie & Fitch price target raised to $39 from $35 at JPMorgan
04/11/22 JPMorgan
Abercrombie & Fitch price target lowered to $35 from $41 at JPMorgan
03/16/22 B. Riley
B. Riley says teen/young adult apparel 'poised for a breakout'
AEO American Eagle
$13.23 /

-0.09 (-0.68%)

05/23/22 Citi
American Eagle downgraded to Neutral from Buy at Citi
05/17/22 B. Riley
American Eagle price target lowered to $32 from $41 at B. Riley
05/16/22 JPMorgan
American Eagle price target lowered to $20 from $29 at JPMorgan
04/11/22 JPMorgan
American Eagle price target lowered to $29 from $32 at JPMorgan
CRI Carter's
$76.62 /

+1.13 (+1.50%)

05/23/22 Citi
Carter's downgraded to Sell from Buy at Citi
04/27/22 BofA
Carter's downgraded to Underperform from Buy at BofA
04/05/22 Wells Fargo
Carter's price target lowered to $95 from $105 at Wells Fargo
03/07/22 Wedbush
Carter's upgraded to Outperform from Neutral at Wedbush
PLCE Children's Place
$43.55 /

-2.07 (-4.54%)

05/23/22 Citi
Children's Place downgraded to Sell from Neutral at Citi
05/20/22 Citi
Children's Place price target lowered to $48 from $60 at Citi
05/17/22 B. Riley
Children's Place price target lowered to $84 from $105 at B. Riley
03/23/22 UBS
Children's Place price target lowered to $60 from $85 at UBS
KSS Kohl's
$39.31 /

+0.13 (+0.33%)

05/23/22 Citi
Kohl's downgraded to Neutral from Buy at Citi
05/20/22 Morgan Stanley
Kohl's price target lowered to $38 from $42 at Morgan Stanley
05/20/22 Cowen
Kohl's price target lowered to $60 from $75 at Cowen
05/20/22 Deutsche Bank
Kohl's price target lowered to $68 from $85 at Deutsche Bank
RL Ralph Lauren
$91.91 /

-1.33 (-1.43%)

05/23/22 Citi
Ralph Lauren downgraded to Neutral from Buy at Citi
05/18/22 Credit Suisse
Ralph Lauren price target lowered to $130 from $165 at Credit Suisse
05/16/22 Deutsche Bank
Ralph Lauren price target lowered to $116 from $136 at Deutsche Bank
04/05/22 Wells Fargo
Ralph Lauren downgraded to Equal Weight from Overweight at Wells Fargo
UA Under Armour
$8.51 /

+0.04 (+0.47%)

05/23/22 Citi
Under Armour downgraded to Neutral from Buy at Citi
05/19/22 Morgan Stanley
Under Armour downgraded to Equal Weight from Overweight at Morgan Stanley
05/10/22 Barclays
Under Armour price target lowered to $14 from $22 at Barclays
05/09/22 B. Riley
Under Armour price target lowered to $11 from $18 at B. Riley
UAA Under Armour
$9.61 /

-0.02 (-0.21%)

05/19/22 Williams Trading
Under Armour downgraded to Hold from Buy at Williams Trading
05/11/22 Argus
Under Armour price target lowered to $15 from $19 at Argus
TSLA Tesla
$665.05 /

+0.95 (+0.14%)

05/23/22 Mizuho
Nio could be back to pre-shutdown levels by June, says Mizuho
05/19/22 Wedbush
Tesla price target lowered to $1,000 from $1,400 at Wedbush
05/18/22 Exane BNP Paribas
Tesla gets price target cut after losing Exane's 'EV World Cup'
05/18/22 Piper Sandler
Tesla price target lowered to $1,035 from $1,260 at Piper Sandler
TWTR Twitter
$37.73 /

-0.55 (-1.44%)

05/17/22 Wedbush
Tesla shares likely to be under pressure again Tuesday, says Wedbush
05/16/22 Wedbush
Bot issue likely excuse for lower Twitter price or Musk walks away, says Wedbush
05/16/22 Citi
Citi does not expect Twitter deal changes from spam review
05/13/22 Truist
Twitter, Musk deal could get 'messy' if he tries to walk away, says Truist
AAPL Apple
$141.26 /

+3.68 (+2.67%)

05/23/22 UBS
UBS finds solid iPhone purchase demand in China, modest U.S. downtick for Apple
05/20/22 Wedbush
Apple a compelling name to own, ride out market storm, says Wedbush
05/19/22 BofA
BofA raises iPhone estimates, trims Apple price target to $200
AMZN Amazon.com
$2,108.51 /

-44.6 (-2.07%)

05/20/22 Citi
Amazon.com removed from Focus List at Citi
05/10/22 Morgan Stanley
Expectations for Affirm outlook 'meaningfully' lower, says Morgan Stanley
05/10/22 Morgan Stanley
Morgan Stanley sees 300% upside potential for Rivian in base case
GILT Gilat Satellite
$6.86 /

+0.125 (+1.86%)

RSLS ReShape Lifesciences
/

+

03/29/22 Alliance Global Partners
ReShape Lifesciences target cut to $5.50 from $10.25 at Alliance Global Partners
03/29/22 Maxim
ReShape Lifesciences price target lowered to $4 from $8 at Maxim
10/08/21 Maxim
ReShape Lifesciences initiated with a Buy at Maxim
10/08/21 Maxim
ReShape Lifesciences initiated with a Buy at Maxim
TBLT ToughBuilt
$6.36 /

-0.43 (-6.33%)

10/19/21 H.C. Wainwright
ToughBuilt initiated with a Buy at H.C. Wainwright
TFX Teleflex
$288.18 /

+1.09 (+0.38%)

05/23/22 Truist
Teleflex price target lowered to $317 from $340 at Truist
05/23/22 RBC Capital
Teleflex price target lowered to $380 from $390 at RBC Capital
05/09/22 BofA
Teleflex initiated with a Neutral at BofA
04/29/22 Truist
Teleflex price target lowered to $340 from $370 at Truist
STRR Star Equity
/

+

XPEV XPeng
$21.58 /

-1.705 (-7.32%)

VMW VMware
$115.50 /

+19.79 (+20.68%)

UA Under Armour
$8.51 /

+0.04 (+0.47%)

TWTR Twitter
$37.73 /

-0.55 (-1.44%)

TSLA Tesla
$665.05 /

+0.95 (+0.14%)

TFX Teleflex
$288.18 /

+1.09 (+0.38%)

TBLT ToughBuilt
$6.36 /

-0.43 (-6.33%)

STRR Star Equity
/

+

SBUX Starbucks
$73.88 /

+0.48 (+0.65%)

RSLS ReShape Lifesciences
/

+

RL Ralph Lauren
$91.91 /

-1.33 (-1.43%)

PLCE Children's Place
$43.55 /

-2.07 (-4.54%)

NVDA Nvidia
$166.37 /

-0.81 (-0.48%)

NTNX Nutanix
$21.91 /

+1.25 (+6.05%)

KSS Kohl's
$39.31 /

+0.13 (+0.33%)

JPM JPMorgan
$126.15 /

+8.77 (+7.47%)

HPQ HP Inc.
$34.73 /

+0.07 (+0.20%)

GPS Gap
$10.61 /

-0.32 (-2.93%)

GILT Gilat Satellite
$6.86 /

+0.125 (+1.86%)

ETTX Entasis Therapeutics
$2.18 /

+0.365 (+20.11%)

EA Electronic Arts
$133.71 /

+3.02 (+2.31%)

DIDI Didi
$1.53 /

+0.025 (+1.66%)

CRI Carter's
$76.62 /

+1.13 (+1.50%)

AXL American Axle
$7.55 /

+0.8 (+11.85%)

AVGO Broadcom
$530.00 /

-14.19 (-2.61%)

ANF Abercrombie & Fitch
$27.32 /

-0.67 (-2.39%)

AMZN Amazon.com
$2,108.51 /

-44.6 (-2.07%)

AEO American Eagle
$13.23 /

-0.09 (-0.68%)

ADSK Autodesk
$181.21 /

-10.295 (-5.38%)

ABBV AbbVie
$150.38 /

-0.66 (-0.44%)

AAPL Apple
$141.26 /

+3.68 (+2.67%)

  • 20
    Jan
  • 30
    Jun
XPEV XPeng
$21.58 /

-1.705 (-7.32%)

VMW VMware
$115.50 /

+19.79 (+20.68%)

UA Under Armour
$8.51 /

+0.04 (+0.47%)

TWTR Twitter
$37.73 /

-0.55 (-1.44%)

TSLA Tesla
$665.05 /

+0.95 (+0.14%)

SBUX Starbucks
$73.88 /

+0.48 (+0.65%)

RL Ralph Lauren
$91.91 /

-1.33 (-1.43%)

NVDA Nvidia
$166.37 /

-0.81 (-0.48%)

NTNX Nutanix
$21.91 /

+1.25 (+6.05%)

KSS Kohl's
$39.31 /

+0.13 (+0.33%)

JPM JPMorgan
$126.15 /

+8.77 (+7.47%)

HPQ HP Inc.
$34.73 /

+0.07 (+0.20%)

GPS Gap
$10.61 /

-0.32 (-2.93%)

EA Electronic Arts
$133.71 /

+3.02 (+2.31%)

DIDI Didi
$1.53 /

+0.025 (+1.66%)

AXL American Axle
$7.55 /

+0.8 (+11.85%)

AVGO Broadcom
$530.00 /

-14.19 (-2.61%)

AMZN Amazon.com
$2,108.51 /

-44.6 (-2.07%)

ABBV AbbVie
$150.38 /

-0.66 (-0.44%)

AAPL Apple
$141.26 /

+3.68 (+2.67%)

XPEV XPeng
$21.58 /

-1.705 (-7.32%)

VMW VMware
$115.50 /

+19.79 (+20.68%)

UA Under Armour
$8.51 /

+0.04 (+0.47%)

TWTR Twitter
$37.73 /

-0.55 (-1.44%)

TSLA Tesla
$665.05 /

+0.95 (+0.14%)

TFX Teleflex
$288.18 /

+1.09 (+0.38%)

SBUX Starbucks
$73.88 /

+0.48 (+0.65%)

RL Ralph Lauren
$91.91 /

-1.33 (-1.43%)

PLCE Children's Place
$43.55 /

-2.07 (-4.54%)

NVDA Nvidia
$166.37 /

-0.81 (-0.48%)

NTNX Nutanix
$21.91 /

+1.25 (+6.05%)

KSS Kohl's
$39.31 /

+0.13 (+0.33%)

JPM JPMorgan
$126.15 /

+8.77 (+7.47%)

HPQ HP Inc.
$34.73 /

+0.07 (+0.20%)

GPS Gap
$10.61 /

-0.32 (-2.93%)

GILT Gilat Satellite
$6.86 /

+0.125 (+1.86%)

ETTX Entasis Therapeutics
$2.18 /

+0.365 (+20.11%)

EA Electronic Arts
$133.71 /

+3.02 (+2.31%)

DIDI Didi
$1.53 /

+0.025 (+1.66%)

CRI Carter's
$76.62 /

+1.13 (+1.50%)

AXL American Axle
$7.55 /

+0.8 (+11.85%)

AVGO Broadcom
$530.00 /

-14.19 (-2.61%)

ANF Abercrombie & Fitch
$27.32 /

-0.67 (-2.39%)

AEO American Eagle
$13.23 /

-0.09 (-0.68%)

ADSK Autodesk
$181.21 /

-10.295 (-5.38%)

ABBV AbbVie
$150.38 /

-0.66 (-0.44%)

XPEV XPeng
$21.58 /

-1.705 (-7.32%)

VMW VMware
$115.50 /

+19.79 (+20.68%)

UAA Under Armour
$9.61 /

-0.02 (-0.21%)

UA Under Armour
$8.51 /

+0.04 (+0.47%)

TWTR Twitter
$37.73 /

-0.55 (-1.44%)

TSLA Tesla
$665.05 /

+0.95 (+0.14%)

SBUX Starbucks
$73.88 /

+0.48 (+0.65%)

RL Ralph Lauren
$91.91 /

-1.33 (-1.43%)

NVDA Nvidia
$166.37 /

-0.81 (-0.48%)

NTNX Nutanix
$21.91 /

+1.25 (+6.05%)

KSS Kohl's
$39.31 /

+0.13 (+0.33%)

JPM JPMorgan
$126.15 /

+8.77 (+7.47%)

HPQ HP Inc.
$34.73 /

+0.07 (+0.20%)

GPS Gap
$10.61 /

-0.32 (-2.93%)

EA Electronic Arts
$133.71 /

+3.02 (+2.31%)

DIDI Didi
$1.53 /

+0.025 (+1.66%)

AVGO Broadcom
$530.00 /

-14.19 (-2.61%)

AMZN Amazon.com
$2,108.51 /

-44.6 (-2.07%)

AEO American Eagle
$13.23 /

-0.09 (-0.68%)

ADSK Autodesk
$181.21 /

-10.295 (-5.38%)

ABBV AbbVie
$150.38 /

-0.66 (-0.44%)

AAPL Apple
$141.26 /

+3.68 (+2.67%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:53
05/23/22
05/23
09:53
05/23/22
09:53
ANF

Abercrombie & Fitch

$26.61 /

-1.38 (-4.93%)

, FTCI

FTC Solar

$3.65 /

-0.185 (-4.82%)

, ARRY

Array Technologies

$8.82 /

-0.255 (-2.81%)

, APLD

Applied Blockchain

$3.73 /

+0.095 (+2.61%)

, WAB

Wabtec

$88.27 /

+1.265 (+1.45%)

, RDUS

Radius Health

$6.24 /

-0.005 (-0.08%)

, AMGN

Amgen

$248.83 /

+1.31 (+0.53%)

, HZNP

Horizon Therapeutics

$88.88 /

-1.44 (-1.59%)

, GILD

Gilead

$64.37 /

+0.525 (+0.82%)

, VRTX

Vertex Pharmaceuticals

$260.33 /

+1.51 (+0.58%)

, PFE

Pfizer

$53.19 /

+0.715 (+1.36%)

, ROIV

Roivant Sciences

$3.85 /

+0.13 (+3.49%)

, SNY

Sanofi

$54.94 /

+0.56 (+1.03%)

, REGN

Regeneron

$671.89 /

+12.36 (+1.87%)

, LLY

Eli Lilly

$301.34 /

+2.43 (+0.81%)

, ABBV

AbbVie

$150.50 /

-0.54 (-0.36%)

, FTDR

Frontdoor

$25.71 /

-0.735 (-2.78%)

, ATHX

Athersys

/

+

, HPQ

HP Inc.

$34.48 /

-0.18 (-0.52%)

, ADSK

Autodesk

$178.14 /

-13.36 (-6.98%)

, CRI

Carter's

$73.96 /

-1.53 (-2.03%)

, PLCE

Children's Place

$42.40 /

-3.22 (-7.06%)

, AEO

American Eagle

$12.86 /

-0.46 (-3.45%)

, KSS

Kohl's

$37.69 /

-1.49 (-3.80%)

, RL

Ralph Lauren

$93.00 /

-0.24 (-0.26%)

, UAA

Under Armour

$9.51 /

-0.12 (-1.25%)

, UA

Under Armour

$8.39 /

-0.08 (-0.94%)

, MSI

Motorola Solutions

$213.79 /

+3.42 (+1.63%)

, THS

TreeHouse

$39.60 /

+2.905 (+7.92%)

, ZBRA

Zebra Technologies

$327.83 /

+2.41 (+0.74%)

, CUBE

CubeSmart

$42.15 /

+1.3 (+3.18%)

, SAIA

Saia

$195.00 /

+7.82 (+4.18%)

, GPS

Gap

$10.47 /

-0.46 (-4.21%)

Institutional investors…

ShowHide Related Items >><<
ZBRA Zebra Technologies
$327.83 /

+2.41 (+0.74%)

WAB Wabtec
$88.27 /

+1.265 (+1.45%)

VRTX Vertex Pharmaceuticals
$260.33 /

+1.51 (+0.58%)

UAA Under Armour
$9.51 /

-0.12 (-1.25%)

UA Under Armour
$8.39 /

-0.08 (-0.94%)

THS TreeHouse
$39.60 /

+2.905 (+7.92%)

SNY Sanofi
$54.94 /

+0.56 (+1.03%)

SAIA Saia
$195.00 /

+7.82 (+4.18%)

ROIV Roivant Sciences
$3.85 /

+0.13 (+3.49%)

RL Ralph Lauren
$93.00 /

-0.24 (-0.26%)

REGN Regeneron
$671.89 /

+12.36 (+1.87%)

RDUS Radius Health
$6.24 /

-0.005 (-0.08%)

PLCE Children's Place
$42.40 /

-3.22 (-7.06%)

PFE Pfizer
$53.19 /

+0.715 (+1.36%)

MSI Motorola Solutions
$213.79 /

+3.42 (+1.63%)

LLY Eli Lilly
$301.34 /

+2.43 (+0.81%)

KSS Kohl's
$37.69 /

-1.49 (-3.80%)

HZNP Horizon Therapeutics
$88.88 /

-1.44 (-1.59%)

HPQ HP Inc.
$34.48 /

-0.18 (-0.52%)

GPS Gap
$10.47 /

-0.46 (-4.21%)

GILD Gilead
$64.37 /

+0.525 (+0.82%)

FTDR Frontdoor
$25.71 /

-0.735 (-2.78%)

FTCI FTC Solar
$3.65 /

-0.185 (-4.82%)

CRI Carter's
$73.96 /

-1.53 (-2.03%)

ATHX Athersys
/

+

ARRY Array Technologies
$8.82 /

-0.255 (-2.81%)

APLD Applied Blockchain
$3.73 /

+0.095 (+2.61%)

ANF Abercrombie & Fitch
$26.61 /

-1.38 (-4.93%)

AMGN Amgen
$248.83 /

+1.31 (+0.53%)

AEO American Eagle
$12.86 /

-0.46 (-3.45%)

ADSK Autodesk
$178.14 /

-13.36 (-6.98%)

ABBV AbbVie
$150.50 /

-0.54 (-0.36%)

ANF Abercrombie & Fitch
$26.61 /

-1.38 (-4.93%)

05/23/22 Citi
Abercrombie & Fitch downgraded to Neutral from Buy at Citi
05/16/22 JPMorgan
Abercrombie & Fitch price target raised to $39 from $35 at JPMorgan
04/11/22 JPMorgan
Abercrombie & Fitch price target lowered to $35 from $41 at JPMorgan
03/16/22 B. Riley
B. Riley says teen/young adult apparel 'poised for a breakout'
FTCI FTC Solar
$3.65 /

-0.185 (-4.82%)

05/23/22 Northland
FTC Solar initiated with an Outperform at Northland
05/11/22 Cowen
FTC Solar price target lowered to $6 from $10 at Cowen
05/10/22 Raymond James
FTC Solar price target lowered to $7 from $10 at Raymond James
04/21/22 Piper Sandler
FTC Solar downgraded to sell on likely guidance cut at Piper Sandler
ARRY Array Technologies
$8.82 /

-0.255 (-2.81%)

05/23/22 Northland
Array Technologies initiated with an Outperform at Northland
05/12/22 Truist
Array Technologies price target lowered to $8 from $14 at Truist
05/11/22 Roth Capital
Array Technologies downgraded to Neutral from Buy at Roth Capital
APLD Applied Blockchain
$3.73 /

+0.095 (+2.61%)

05/23/22 Craig-Hallum
Craig-Hallum bullish on Applied Blockchain, initiates with a Buy
05/23/22 Craig-Hallum
Applied Blockchain initiated with a Buy at Craig-Hallum
05/09/22 Lake Street
Applied Blockchain initiated with a Buy at Lake Street
05/09/22 Northland
Applied Blockchain initiated with an Outperform at Northland
WAB Wabtec
$88.27 /

+1.265 (+1.45%)

05/23/22 Atlantic Equities
Wabtec initiated with Overweight, $101 target at Atlantic Equities
05/23/22 Atlantic Equities
Wabtec initiated with an Overweight at Atlantic Equities
04/28/22 Wolfe Research
Wabtec upgraded to Peer Perform from Underperform at Wolfe Research
01/10/22 Wells Fargo
Wabtec price target raised to $110 from $105 at Wells Fargo
RDUS Radius Health
$6.24 /

-0.005 (-0.08%)

05/23/22 SVB Leerink
Radius Health initiated with a Market Perform at SVB Leerink
12/23/21 Stifel
New Radius' Tymlos label offers slight expansion potential, says Stifel
12/10/21 Morgan Stanley
Radius Health downgraded to Underweight from Equal Weight at Morgan Stanley
12/09/21 Goldman Sachs
Radius Health downgraded to Neutral from Buy at Goldman Sachs
AMGN Amgen
$248.83 /

+1.31 (+0.53%)

05/23/22 SVB Leerink
Amgen initiated with a Market Perform at SVB Leerink
05/10/22 Mizuho
Amgen price target raised to $208 from $202 at Mizuho
05/05/22 Stifel
ASCO sets up as 'downside-biased' for Mirati investors, says Stifel
HZNP Horizon Therapeutics
$88.88 /

-1.44 (-1.59%)

05/23/22 SVB Leerink
Horizon Therapeutics initiated with a Market Perform at SVB Leerink
03/14/22 Oppenheimer
Horizon Therapeutics initiated with an Outperform at Oppenheimer
01/26/22 Piper Sandler
Horizon Therapeutics price target lowered to $133 from $143 at Piper Sandler
01/18/22 JPMorgan
Horizon Therapeutics valuation 'compelling' after selloff, says JPMorgan
GILD Gilead
$64.37 /

+0.525 (+0.82%)

05/23/22 SVB Leerink
Gilead initiated with a Market Perform at SVB Leerink
05/17/22 BMO Capital
Scholar Rock price target lowered to $55 from $74 at BMO Capital
05/16/22 Piper Sandler
Gilead price target lowered to $69 from $73 at Piper Sandler
04/29/22 Piper Sandler
Gilead price target raised to $73 from $72 at Piper Sandler
VRTX Vertex Pharmaceuticals
$260.33 /

+1.51 (+0.58%)

05/23/22 Piper Sandler
Piper Sandler remains bullish on Catalyst after sale of complement portfolio
05/23/22 SVB Leerink
Vertex Pharmaceuticals initiated with a Market Perform at SVB Leerink
05/06/22 Wells Fargo
Vertex Pharmaceuticals price target raised to $305 from $300 at Wells Fargo
05/06/22 Baird
Vertex Pharmaceuticals downgraded to Neutral at Baird after 21% advance
PFE Pfizer
$53.19 /

+0.715 (+1.36%)

05/23/22 Piper Sandler
Biohaven price target lowered to $149 from $170 at Piper Sandler
05/23/22 SVB Leerink
Pfizer initiated with a Market Perform at SVB Leerink
05/11/22 H.C. Wainwright
Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright
05/11/22 Wedbush
Global Blood Therapeutics added to Best Ideas List at Wedbush
ROIV Roivant Sciences
$3.85 /

+0.13 (+3.49%)

05/23/22 SVB Leerink
Roivant Sciences initiated with an Outperform at SVB Leerink
04/29/22 Cantor Fitzgerald
Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
12/15/21 Goldman Sachs
Roivant Sciences initiated with a Buy at Goldman Sachs
12/02/21 H.C. Wainwright
H.C. Wainwright says Arbutus patent win may mean 'considerable gain' for Roivant
SNY Sanofi
$54.94 /

+0.56 (+1.03%)

05/23/22 SVB Leerink
Sanofi initiated with an Outperform at SVB Leerink
05/09/22 Wedbush
Wedbush downgrades Arvinas to Neutral, cuts price target to $43
05/02/22 Guggenheim
Sanofi price target raised to EUR 127 from EUR 121 at Guggenheim
04/28/22 Credit Suisse
Kymera Therapeutics initiated with an Outperform at Credit Suisse
REGN Regeneron
$671.89 /

+12.36 (+1.87%)

05/23/22 SVB Leerink
Regeneron initiated with an Outperform at SVB Leerink
05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
04/20/22 Cowen
Regeneron price target raised to $645 from $640 at Cowen
04/20/22 BTIG
Checkmate Pharmaceuticals downgraded to Neutral from Buy at BTIG
LLY Eli Lilly
$301.34 /

+2.43 (+0.81%)

05/23/22 SVB Leerink
Eli Lilly initiated with an Outperform at SVB Leerink
05/02/22 Wells Fargo
AbbVie price target raised to $200 from $165 at Wells Fargo
05/02/22 Mizuho
Eli Lilly price target raised to $356 from $315 at Mizuho
04/29/22 Morgan Stanley
Eli Lilly price target raised to $369 from $364 at Morgan Stanley
ABBV AbbVie
$150.50 /

-0.54 (-0.36%)

05/23/22 SVB Leerink
AbbVie initiated with an Underperform at SVB Leerink
05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
FTDR Frontdoor
$25.71 /

-0.735 (-2.78%)

05/23/22 Truist
Frontdoor downgraded to Hold at Truist on leadership transition
05/23/22 Truist
Frontdoor downgraded to Hold from Buy at Truist
05/06/22 Truist
Frontdoor price target lowered to $32 from $50 at Truist
05/06/22 Raymond James
Frontdoor price target lowered to $31 from $40 at Raymond James
ATHX Athersys
/

+

05/23/22 BofA
Athersys downgraded to Underperform from Neutral at BofA
11/19/21 BofA
Athersys downgraded to Neutral from Buy at BofA (yesterday)
HPQ HP Inc.
$34.48 /

-0.18 (-0.52%)

05/23/22 Citi
HP Inc. downgraded to Neutral from Buy at Citi
05/18/22 Jefferies
Information Technology sector upgraded to Bullish at Jefferies
05/16/22 Evercore ISI
HP Inc. added to 'Tactical Outperform' list at Evercore ISI
04/08/22 UBS
HP Inc. downgraded to Neutral from Buy at UBS
ADSK Autodesk
$178.14 /

-13.36 (-6.98%)

05/23/22 Stifel
Autodesk price target lowered to $230 from $285 at Stifel
05/23/22 RBC Capital
Autodesk price target lowered to $255 from $295 at RBC Capital
05/23/22 Deutsche Bank
Deutsche Bank downgrades Autodesk on risk to consensus estimates
05/23/22 Deutsche Bank
Autodesk downgraded to Hold from Buy at Deutsche Bank
CRI Carter's
$73.96 /

-1.53 (-2.03%)

05/23/22 Citi
Carter's downgraded to Sell from Buy at Citi
04/27/22 BofA
Carter's downgraded to Underperform from Buy at BofA
04/05/22 Wells Fargo
Carter's price target lowered to $95 from $105 at Wells Fargo
03/07/22 Wedbush
Carter's upgraded to Outperform from Neutral at Wedbush
PLCE Children's Place
$42.40 /

-3.22 (-7.06%)

05/23/22 Citi
Children's Place downgraded to Sell from Neutral at Citi
05/20/22 Citi
Children's Place price target lowered to $48 from $60 at Citi
05/17/22 B. Riley
Children's Place price target lowered to $84 from $105 at B. Riley
03/23/22 UBS
Children's Place price target lowered to $60 from $85 at UBS
AEO American Eagle
$12.86 /

-0.46 (-3.45%)

05/23/22 Citi
American Eagle downgraded to Neutral from Buy at Citi
05/17/22 B. Riley
American Eagle price target lowered to $32 from $41 at B. Riley
05/16/22 JPMorgan
American Eagle price target lowered to $20 from $29 at JPMorgan
04/11/22 JPMorgan
American Eagle price target lowered to $29 from $32 at JPMorgan
KSS Kohl's
$37.69 /

-1.49 (-3.80%)

05/23/22 Citi
Kohl's downgraded to Neutral from Buy at Citi
05/20/22 Morgan Stanley
Kohl's price target lowered to $38 from $42 at Morgan Stanley
05/20/22 Cowen
Kohl's price target lowered to $60 from $75 at Cowen
05/20/22 Deutsche Bank
Kohl's price target lowered to $68 from $85 at Deutsche Bank
RL Ralph Lauren
$93.00 /

-0.24 (-0.26%)

05/23/22 Citi
Ralph Lauren downgraded to Neutral from Buy at Citi
05/18/22 Credit Suisse
Ralph Lauren price target lowered to $130 from $165 at Credit Suisse
05/16/22 Deutsche Bank
Ralph Lauren price target lowered to $116 from $136 at Deutsche Bank
04/05/22 Wells Fargo
Ralph Lauren downgraded to Equal Weight from Overweight at Wells Fargo
UAA Under Armour
$9.51 /

-0.12 (-1.25%)

05/23/22 Citi
Under Armour downgraded to Neutral from Buy at Citi
05/19/22 Williams Trading
Under Armour downgraded to Hold from Buy at Williams Trading
05/19/22 Morgan Stanley
Under Armour downgraded to Equal Weight from Overweight at Morgan Stanley
05/11/22 Argus
Under Armour price target lowered to $15 from $19 at Argus
UA Under Armour
$8.39 /

-0.08 (-0.94%)

05/10/22 Barclays
Under Armour price target lowered to $14 from $22 at Barclays
05/09/22 B. Riley
Under Armour price target lowered to $11 from $18 at B. Riley
MSI Motorola Solutions
$213.79 /

+3.42 (+1.63%)

05/23/22 Morgan Stanley
Motorola Solutions assumed at Overweight from Equal Weight at Morgan Stanley
05/09/22 Credit Suisse
Credit Suisse starts Axon at Outperform with $169 price target
05/09/22 Credit Suisse
Credit Suisse starts Tyler Technologies at Neutral with $408 price target
04/25/22 Loop Capital
Motorola Solutions initiated with a Buy at Loop Capital
THS TreeHouse
$39.60 /

+2.905 (+7.92%)

05/23/22 Truist
TreeHouse upgraded to Buy from Hold at Truist
05/23/22 Truist
TreeHouse upgraded to Buy from Hold at Truist
03/22/22 Truist
TreeHouse price target lowered to $35 from $40 at Truist
ZBRA Zebra Technologies
$327.83 /

+2.41 (+0.74%)

05/23/22 Morgan Stanley
Zebra Technologies assumed at Equal Weight from Underweight at Morgan Stanley
05/04/22 Needham
Zebra Technologies price target lowered to $500 from $535 at Needham
05/04/22 Baird
Zebra Technologies price target lowered to $440 from $550 at Baird
04/12/22 Morgan Stanley
Morgan Stanley cuts Telecom & Networking Equipment industry view to Cautious
CUBE CubeSmart
$42.15 /

+1.3 (+3.18%)

05/23/22 Raymond James
CubeSmart upgraded to Strong Buy from Outperform at Raymond James
05/23/22 Raymond James
CubeSmart upgraded to Strong Buy from Outperform at Raymond James
05/16/22 Truist
CubeSmart price target lowered to $48 from $55 at Truist
04/04/22 JPMorgan
CubeSmart price target raised to $58 from $57 at JPMorgan
SAIA Saia
$195.00 /

+7.82 (+4.18%)

05/23/22 UBS
Saia upgraded to Buy from Neutral at UBS
05/19/22 Citi
Saia price target lowered to $190 from $230 at Citi
05/03/22 Wells Fargo
Saia price target raised to $290 from $273 at Wells Fargo
04/20/22 Raymond James
Saia price target lowered to $275 from $350 at Raymond James
GPS Gap
$10.47 /

-0.46 (-4.21%)

05/23/22 Citi
Gap downgraded to Sell from Neutral at Citi
05/17/22 UBS
Gap price target lowered to $14 from $18 at UBS
05/16/22 JPMorgan
Gap price target lowered to $11 from $14 at JPMorgan
04/25/22 Guggenheim
Guggenheim upgrades Gap to Buy with shares 70% off highs
ZBRA Zebra Technologies
$327.83 /

+2.41 (+0.74%)

WAB Wabtec
$88.27 /

+1.265 (+1.45%)

VRTX Vertex Pharmaceuticals
$260.33 /

+1.51 (+0.58%)

UAA Under Armour
$9.51 /

-0.12 (-1.25%)

THS TreeHouse
$39.60 /

+2.905 (+7.92%)

SNY Sanofi
$54.94 /

+0.56 (+1.03%)

SAIA Saia
$195.00 /

+7.82 (+4.18%)

ROIV Roivant Sciences
$3.85 /

+0.13 (+3.49%)

RL Ralph Lauren
$93.00 /

-0.24 (-0.26%)

REGN Regeneron
$671.89 /

+12.36 (+1.87%)

RDUS Radius Health
$6.24 /

-0.005 (-0.08%)

PLCE Children's Place
$42.40 /

-3.22 (-7.06%)

PFE Pfizer
$53.19 /

+0.715 (+1.36%)

MSI Motorola Solutions
$213.79 /

+3.42 (+1.63%)

LLY Eli Lilly
$301.34 /

+2.43 (+0.81%)

KSS Kohl's
$37.69 /

-1.49 (-3.80%)

HZNP Horizon Therapeutics
$88.88 /

-1.44 (-1.59%)

HPQ HP Inc.
$34.48 /

-0.18 (-0.52%)

GPS Gap
$10.47 /

-0.46 (-4.21%)

GILD Gilead
$64.37 /

+0.525 (+0.82%)

FTDR Frontdoor
$25.71 /

-0.735 (-2.78%)

FTCI FTC Solar
$3.65 /

-0.185 (-4.82%)

CUBE CubeSmart
$42.15 /

+1.3 (+3.18%)

CRI Carter's
$73.96 /

-1.53 (-2.03%)

ATHX Athersys
/

+

ARRY Array Technologies
$8.82 /

-0.255 (-2.81%)

ANF Abercrombie & Fitch
$26.61 /

-1.38 (-4.93%)

AMGN Amgen
$248.83 /

+1.31 (+0.53%)

AEO American Eagle
$12.86 /

-0.46 (-3.45%)

ADSK Autodesk
$178.14 /

-13.36 (-6.98%)

ABBV AbbVie
$150.50 /

-0.54 (-0.36%)

  • 13
    Apr
  • 17
    Nov
VRTX Vertex Pharmaceuticals
$260.33 /

+1.51 (+0.58%)

UAA Under Armour
$9.51 /

-0.12 (-1.25%)

SNY Sanofi
$54.94 /

+0.56 (+1.03%)

RL Ralph Lauren
$93.00 /

-0.24 (-0.26%)

REGN Regeneron
$671.89 /

+12.36 (+1.87%)

PFE Pfizer
$53.19 /

+0.715 (+1.36%)

LLY Eli Lilly
$301.34 /

+2.43 (+0.81%)

KSS Kohl's
$37.69 /

-1.49 (-3.80%)

HPQ HP Inc.
$34.48 /

-0.18 (-0.52%)

GPS Gap
$10.47 /

-0.46 (-4.21%)

GILD Gilead
$64.37 /

+0.525 (+0.82%)

FTCI FTC Solar
$3.65 /

-0.185 (-4.82%)

AMGN Amgen
$248.83 /

+1.31 (+0.53%)

ABBV AbbVie
$150.50 /

-0.54 (-0.36%)

ZBRA Zebra Technologies
$327.83 /

+2.41 (+0.74%)

WAB Wabtec
$88.27 /

+1.265 (+1.45%)

VRTX Vertex Pharmaceuticals
$260.33 /

+1.51 (+0.58%)

UAA Under Armour
$9.51 /

-0.12 (-1.25%)

THS TreeHouse
$39.60 /

+2.905 (+7.92%)

SNY Sanofi
$54.94 /

+0.56 (+1.03%)

SAIA Saia
$195.00 /

+7.82 (+4.18%)

ROIV Roivant Sciences
$3.85 /

+0.13 (+3.49%)

RL Ralph Lauren
$93.00 /

-0.24 (-0.26%)

REGN Regeneron
$671.89 /

+12.36 (+1.87%)

RDUS Radius Health
$6.24 /

-0.005 (-0.08%)

PLCE Children's Place
$42.40 /

-3.22 (-7.06%)

PFE Pfizer
$53.19 /

+0.715 (+1.36%)

MSI Motorola Solutions
$213.79 /

+3.42 (+1.63%)

LLY Eli Lilly
$301.34 /

+2.43 (+0.81%)

KSS Kohl's
$37.69 /

-1.49 (-3.80%)

HZNP Horizon Therapeutics
$88.88 /

-1.44 (-1.59%)

HPQ HP Inc.
$34.48 /

-0.18 (-0.52%)

GPS Gap
$10.47 /

-0.46 (-4.21%)

GILD Gilead
$64.37 /

+0.525 (+0.82%)

FTCI FTC Solar
$3.65 /

-0.185 (-4.82%)

CRI Carter's
$73.96 /

-1.53 (-2.03%)

ARRY Array Technologies
$8.82 /

-0.255 (-2.81%)

APLD Applied Blockchain
$3.73 /

+0.095 (+2.61%)

ANF Abercrombie & Fitch
$26.61 /

-1.38 (-4.93%)

AMGN Amgen
$248.83 /

+1.31 (+0.53%)

AEO American Eagle
$12.86 /

-0.46 (-3.45%)

ADSK Autodesk
$178.14 /

-13.36 (-6.98%)

ABBV AbbVie
$150.50 /

-0.54 (-0.36%)

ZBRA Zebra Technologies
$327.83 /

+2.41 (+0.74%)

VRTX Vertex Pharmaceuticals
$260.33 /

+1.51 (+0.58%)

UAA Under Armour
$9.51 /

-0.12 (-1.25%)

UA Under Armour
$8.39 /

-0.08 (-0.94%)

ROIV Roivant Sciences
$3.85 /

+0.13 (+3.49%)

RL Ralph Lauren
$93.00 /

-0.24 (-0.26%)

RDUS Radius Health
$6.24 /

-0.005 (-0.08%)

PFE Pfizer
$53.19 /

+0.715 (+1.36%)

LLY Eli Lilly
$301.34 /

+2.43 (+0.81%)

KSS Kohl's
$37.69 /

-1.49 (-3.80%)

HPQ HP Inc.
$34.48 /

-0.18 (-0.52%)

GPS Gap
$10.47 /

-0.46 (-4.21%)

GILD Gilead
$64.37 /

+0.525 (+0.82%)

FTCI FTC Solar
$3.65 /

-0.185 (-4.82%)

ATHX Athersys
/

+

ARRY Array Technologies
$8.82 /

-0.255 (-2.81%)

AMGN Amgen
$248.83 /

+1.31 (+0.53%)

AEO American Eagle
$12.86 /

-0.46 (-3.45%)

ADSK Autodesk
$178.14 /

-13.36 (-6.98%)

ABBV AbbVie
$150.50 /

-0.54 (-0.36%)

Hot Stocks
AbbVie's cariprazine for MDD achieves primary endpoint in Phase 3 study » 08:05
05/23/22
05/23
08:05
05/23/22
08:05
ABBV

AbbVie

$151.04 /

-0.8 (-0.53%)

, RGEDF

Richter Gedeon

$24.63 /

+ (+0.00%)

AbbVie (ABBV) will…

AbbVie (ABBV) will present positive data from a Phase 3 trial of cariprazine for the adjunctive treatment of major depressive disorder - MDD - in patients with an inadequate response to ongoing antidepressant therapy. The study met its primary endpoint of statistically significant improvement in patients compared with placebo. These results will be presented on May 24, at the American Psychiatric Association Annual Meeting in New Orleans. AbbVie's supplemental New Drug Application for cariprazine was supported by two positive registration-enabling studies. The sNDA is currently under review by the FDA for expanded use in the adjunctive treatment of MDD with a decision expected by year-end. Safety data was consistent with the established safety profile of cariprazine across indications. There were no deaths in the trial, with serious adverse events (SAE) occurring in both treatment and placebo groups. The most common adverse events in the treatment group were akathisia and nausea. Cariprazine is marketed as Vraylar in the U.S. and is FDA-approved to treat adults with depressive, acute manic and mixed episodes associated with bipolar I disorder, as well as schizophrenia. Cariprazine is being co-developed by AbbVie and Gedeon Richter (RGEDF).

ShowHide Related Items >><<
ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

05/23/22 SVB Leerink
AbbVie initiated with an Underperform at SVB Leerink
05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
RGEDF Richter Gedeon
$24.63 /

+ (+0.00%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

Initiation
AbbVie initiated with an Underperform at SVB Leerink » 06:23
05/23/22
05/23
06:23
05/23/22
06:23
ABBV

AbbVie

$151.04 /

-0.8 (-0.53%)

SVB Leerink analyst David…

SVB Leerink analyst David Risinger initiated coverage of AbbVie with an Underperform rating and $140 price target. Management has delivered "exceptional performance," but the analyst projects 2024-2025 EPS 6%-8% below consensus due to Humira biosimilar pressures accelerating in mid-2023 when several biosimilars launch and AbbVie's business reinvestment requirements. Risinger sees the stock as a crowded defensive play, and anticipates downward analyst revisions ahead for 2024-2025 EPS as AbbVie's financial picture becomes clearer. He highly respects the management team's execution and performance to date and notes that "this is a stock call, not a call on the quality of the company."

ShowHide Related Items >><<
ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
05/02/22 Morgan Stanley
AbbVie's recent weakness a buying opportunity, says Morgan Stanley
ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

Hot Stocks
AbbVie receives CHMP recommendation for upadacitinib approval » 05:26
05/23/22
05/23
05:26
05/23/22
05:26
ABBV

AbbVie

$151.04 /

-0.8 (-0.53%)

AbbVie announced the…

AbbVie announced the European Medicines Agency's, or EMA, Committee for Medicinal Products for Human Use, or CHMP, adopted an opinion recommending the approval of upadacitinib, 45 mg and 15 mg and 30 mg, for the treatment of adult patients with moderately to severely active ulcerative colitis, or UC, who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

ShowHide Related Items >><<
ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
05/02/22 Morgan Stanley
AbbVie's recent weakness a buying opportunity, says Morgan Stanley
ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

ABBV AbbVie
$151.04 /

-0.8 (-0.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.